Eben Rosenthal
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Eben Rosenthal sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Eben Rosenthal: 8 sponsored US clinical trials, 3 recruiting.
Eben Rosenthal sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck, with 1 trials.
Upper-quartile sponsor footprint
Eben Rosenthal sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
NCT07493447
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
NCT07210632
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
NCT05747625
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer
NCT03405142
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
NCT02855086
Panitumumab IRDye800 Optical Imaging Study
NCT02415881
Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery
NCT02736578
Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
NCT01987375
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 2 |
What is open in the Eben Rosenthal pipeline
3 recruiting of 8 indexed (38% open); 2 completed (25%).
Phase mix: 0 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Eben Rosenthal: open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Eben Rosenthal sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 38% open enrollment (± trial volume)
- American Thrombosis and Hemostasis Network · 38% recruiting · 8 trials
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
Related
What to do with this Eben Rosenthal page
8 registered trials is a research-attention snapshot, not an endorsement of Eben Rosenthal or any single study.
- 3 of Eben Rosenthal's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck is the condition Eben Rosenthal studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Eben Rosenthal pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.